Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2016
Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 78,850,000 $ 81,406,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 32,103,000 27,727,000
Fair Value Write-Up of Acquired Inventory 3,439,000 5,252,000
Deferred income taxes (1,379,000) (794,000)
Stock-based compensation expense $ 6,676,000 4,725,000
Gain on CyVek acquisition (8,300,000)
Other $ (229,000) (34,000)
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables (14,616,000) (7,316,000)
Inventories (4,237,000) (4,882,000)
Prepaid expenses (1,046,000) (595,000)
Trade accounts payable and accrued expenses 5,490,000 1,490,000
Salaries, wages and related accruals 1,896,000 693,000
Income taxes payable 562,000 2,848,000
Net cash provided by operating activities 107,509,000 102,220,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions, net of cash acquired (90,888,000) (420,102,000)
Net proceeds from maturities and purchases of available-for-sale investments 780,000 11,996,000
Additions to property and equipment (13,844,000) (12,971,000)
Distributions from unconsolidated entities 0 106,000
Net cash used in investing activities (103,952,000) (420,971,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (35,698,000) (35,218,000)
Proceeds from stock option exercises 1,923,000 9,732,000
Excess tax benefit from stock option exercises 239,000 392,000
Borrowings under line-of-credit agreement 77,000,000 163,000,000
Payments on line-of-credit (34,500,000) (20,953,000)
Net cash provided by (used in) financing activities 8,964,000 116,953,000
Effect of exchange rate changes on cash and cash equivalents (1,340,000) (10,323,000)
Net increase (decrease) in cash and cash equivalents 11,181,000 (212,121,000)
Cash and cash equivalents at beginning of period 54,532,000 318,568,000
Cash and cash equivalents at end of period $ 65,713,000 $ 106,447,000